# Cumberland Pharmaceuticals Inc: Form 8-K, filed Jan 3, 2020

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2020-01-03
- Accepted by EDGAR: Jan 3, 2020, 17:16 ET
- Period: 2020-01-03
- Accession: 0001628280-20-000118
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828020000118/a8k-proformaclinigenproduc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828020000118/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828020000118/a8k-proformaclinigenproduc.htm

Filed Jan 3, 2020.
Source: SEC EDGAR, the filing index for accession 0001628280-20-000118. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.